Riley Exploration Permian, Inc. is rated a Buy due to strong production and improved balance sheet. Learn more about REPX ...

VKTX remains a Buy for its cheap FY2030 EV/Sales valuations of 2.28x, the strong clinical trial results exceeding legacy ...

An update from TrivarX Limited ( (AU:TRI) ) is now available.

Morgans healthcare analysts give Stockhead readers their top picks for 2026 after a tough year for the sector. ... Read More ...

The company boasts a fortress-like balance sheet with significant cash reserves ($8.4 billion in cash at the end of Q3 2025) ...

Kazia Therapeutics Limited ("Kazia" or the "Company") , a clinical-stage oncology company focused on developing innovative therapies for cancer, today announced that it has regained full compliance ...

Amazon ( AMZN +0.06%) continues to underscore the strength of its business and deliver fantastic growth for long-term ...

We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. Wave Life Sciences Ltd. tops ...

Restoration of Nasdaq compliance follows $50 million institutional financing and reinforces balance-sheet strength SYDNEY, Dec. 22, 2025 /PRNewswire/ -- Kazia Therapeutics ...

Bicara Therapeutics (BCAX) just picked up a double dose of index recognition, joining both the NASDAQ Biotechnology Index and the S&P Biotechnology Select Industry Index. This shift can quietly ...

VITARICH Corp. on Monday said that it had reached a definitive settlement with AXA Philippines Life and General Insurance Corp., ending an 11-year legal battle over damages sustained during Typhoon ...

The company is financially solid, with over $2 billion in cash and healthy profit margins. While the stock isn’t cheap, its ...